Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
1. To evaluate the dose response of JNJ-54781532 at Week 8 in subjects with moderately to severely active UC. 2. To evaluate the safety of JNJ-54781532 in subjects with moderately to severely active UC.
Inclusion criteria
- Ulcerative colitis